PRLD · Prelude Therapeutics Incorporated

Summary

Prelude Therapeutics Incorporated issued a press release on March 10, 2026, announcing its financial results and financial condition under Item 2.02. The company also prepared investor presentation materials under Item 7.01 to be used in investor communications.

Key takeaways

• Press release dated March 10, 2026 (Exhibit 99.1)
• Investor presentation materials (Exhibit 99.2)
• Item 2.02: Results of Operations and Financial Condition disclosed
• Item 7.01: Regulation FD Disclosure of investor presentation
• Filing date: 2026-03-10